Moderate riskFDA DrugClass II

Accord levothyroxine 137 mcg tablets recalled for subpotency

Accord Healthcare is recalling certain batches of levothyroxine sodium 137 mcg tablets because they contain less active ingredient than labeled. Levothyroxine is a thyroid medication, and tablets that are weaker than expected may not effectively treat hypothyroidism. The recall affects 90-count and 1000-count bottles distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if your levothyroxine matches the affected lot numbers and expiration dates listed in the recall notice.
  2. Contact your pharmacist or doctor if you have one of the recalled batches.
  3. Do not stop taking your levothyroxine without talking to your doctor first; stopping suddenly can be harmful.
  4. Your doctor may want to check your thyroid levels or replace your medication.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 12 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Classification
Class II
Recall number
D-0782-2026

In the FDA's words

Description
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India. Subpotent Drug a) Lot # D2402125, D2402126, D2402127, Exp. Date 09/30/2026. b) Lot #: D2402523, D2402524, Exp. Date 11/30/2026. Distribution: Nationwide within the United States Affected quantity: N/A
Hazard
Subpotent Drug

12 products in this recall

The agency lists each product separately. Check every one you might have.

Related topics

PotencyDrugsSold nationwideMore from FDA Drug